Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 7;7(2):00080-2021.
doi: 10.1183/23120541.00080-2021. eCollection 2021 Apr.

The protective effect of SARS-CoV-2 antibodies in Scottish healthcare workers

Affiliations

The protective effect of SARS-CoV-2 antibodies in Scottish healthcare workers

Hani Abo-Leyah et al. ERJ Open Res. .

Abstract

Background: Healthcare workers (HCWs) are believed to be at increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. It is not known to what extent the natural production of antibodies to SARS-CoV-2 is protective against re-infection.

Methods: A prospective observational study of HCWs in Scotland (UK) from May to September 2020 was performed. The Siemens SARS-CoV-2 total antibody assay was used to establish seroprevalence in this cohort. Controls, matched for age and sex to the general local population, were studied for comparison. New infections (up to 2 December 2020) post antibody testing were recorded to determine whether the presence of SARS-CoV-2 antibodies protects against re-infection.

Results: A total of 2063 health and social care workers were recruited for this study. At enrolment, 300 HCWs had a positive antibody test (14.5%). 11 out of 231 control sera tested positive (4.8%). HCWs therefore had an increased likelihood of a positive test (OR 3.4, 95% CI 1.85-6.16; p<0.0001). Dentists were most likely to test positive. 97.3% of patients who had previously tested positive for SARS-CoV-2 by reverse transcriptase (RT)-PCR had positive antibodies. 18.7% had an asymptomatic infection. There were 38 new infections with SARS-CoV-2 in HCWs who were previously antibody negative, and one symptomatic RT-PCR-positive re-infection. The presence of antibodies was therefore associated with an 85% reduced risk of re-infection with SARS-CoV-2 (hazard ratio 0.15, 95% CI 0.06-0.35; p=0.026).

Conclusion: HCWs were three times more likely to test positive for SARS-CoV-2 than the general population. Almost all infected individuals developed an antibody response, which was 85% effective in protecting against re-infection with SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: H. Abo-Leyah has nothing to disclose. Conflict of interest: S. Gallant has nothing to disclose. Conflict of interest: D. Cassidy has nothing to disclose. Conflict of interest: Y.H. Giam has nothing to disclose. Conflict of interest: J. Killick has nothing to disclose. Conflict of interest: B. Marshall has nothing to disclose. Conflict of interest: G. Hay has nothing to disclose. Conflict of interest: C. Snowdon has nothing to disclose. Conflict of interest: E.J. Hothersall has nothing to disclose. Conflict of interest: T. Pembridge has nothing to disclose. Conflict of interest: R. Strachan has nothing to disclose. Conflict of interest: N. Gallant has nothing to disclose. Conflict of interest: B.J. Parcell has nothing to disclose. Conflict of interest: J. George has nothing to disclose. Conflict of interest: E. Furrie has nothing to disclose. Conflict of interest: J.D. Chalmers reports grants and personal fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Insmed; personal fees from Chiesi, Novartis and Zambon; and grants from Gilead Sciences, all outside the submitted work.

Figures

FIGURE 1
FIGURE 1
Percentage prevalence of SARS-CoV-2 antibody among different healthcare worker roles. Staff working in dentistry had the highest prevalence. AHP: allied health professional; Admin: administrative staff; HCA: healthcare assistant.
FIGURE 2
FIGURE 2
Proportion of antibody detection according to PCR status. 97.3% of PCR-positive individuals had detectable antibodies. 10.9% of PCR-negative participants had detectable antibodies.
FIGURE 3
FIGURE 3
Survival curve showing protective effect of pre-existing antibodies to developing new SARS-CoV-2 infections. Those who had previously detected antibodies to SARS-CoV-2 were protected against re-infection.

Similar articles

Cited by

References

    1. Alhazzani W, Møller MH, Arabi YM, et al. . Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Crit Care Med 2020; 48: e440–e469. doi:10.1097/CCM.0000000000004363 - DOI - PMC - PubMed
    1. Livingston E, Bucher K. Coronavirus disease 2019 (COVID-19) in Italy. JAMA 2020; 323: 1335. doi:10.1001/jama.2020.4344 - DOI - PubMed
    1. Xiao J, Fang M, Chen Q, et al. . SARS, MERS and COVID-19 among healthcare workers: a narrative review. J Infect Public Health 2020; 13: 843–848. doi:10.1016/j.jiph.2020.05.019 - DOI - PMC - PubMed
    1. Nguyen LH, Drew DA, Graham MS, et al. . Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health 2020; 5: e475–e483. doi:10.1016/S2468-2667(20)30164-X - DOI - PMC - PubMed
    1. Thomas JP, Srinivasan A, Wickramarachchi CS, et al. . Evaluating the national PPE guidance for NHS healthcare workers during the COVID-19 pandemic. Clin Med 2020; 20: 242–247. doi:10.7861/clinmed.2020-0143 - DOI - PMC - PubMed

LinkOut - more resources